Vizgen

Vizgen offers spatial transcriptomics and proteomics solutions.

Vizgen offers spatial proteomics products designed to integrate into proteomics workflows.

Vizgen offers spatial transcriptomics products for imaging and analytics.

Spatial transcriptomics data enables simultaneous analysis of gene expression distributions and spatial patterns within tissue. Clustering and spatial domain detection are methods for analyzing these data.

Imaging-based spatial transcriptomics is used to study tumor biology and associated microenvironments.

Spatial transcriptomics technologies reveal single-cell molecular profiles in their spatial tissue context, helping researchers study intratumor heterogeneity and the tumor microenvironment.

Safety Data Sheet for Conditioning Buffer

A U.S. District Court judge granted Vizgen’s motion to expand its antitrust case against 10x Genomics and Harvard University, citing new evidence that surfaced during discovery.

Vizgen is developing next-generation genomics tools to improve spatially resolved transcriptomics.

Vizgen says its mission is to improve human health worldwide.

The page describes Vizgen’s multiomics platforms for spatial transcriptomics and proteomics.

The page explains how Vizgen handles personal information, including data collection, usage, and privacy practices.

Understand the legal agreements and conditions for using Vizgen's services, including the use of their spatial genomics technologies and website

Vizgen introduces new volumetric **MERFISH datasets** for mouse brain and human neurodegenerative brain tissue, generated using its **MERSCOPE Ultra Platform**. The company plans to showcase these spatial data solutions at the **Human Cell Atlas (HCA) 2026 Meeting**, expanding its capabilities in multiomics and tissue mapping. The datasets aim to enhance cellular atlas research with high-resolution spatial insights.

Jun 2026VizgenNews article

Vizgen introduces pre-designed and add-on gene panels to simplify access to its validation and customization services. The company also expands its AI-powered cell segmentation models, aiming to improve workflow efficiency in spatial biology research. These tools support advanced downstream analysis for researchers.

Apr 2026VizgenNews article

Professor Xiaowei Zhuang, founder of Vizgen, receives the 2026 Ernest Solvay Prize for her groundbreaking work behind the **MERSCOPE® Platform**. The award recognizes advancements in imaging technology that enable high-resolution cellular and molecular analysis. Zhuang’s research at Harvard University and her company’s innovations support biological discovery and medical diagnostics.

Apr 2026VizgenNews article

Vizgen expands its MERSCOPE Ultra platform to include spatially resolved molecular profiling of organoids. The company is developing multiple innovations to accelerate drug discovery and advance disease research through spatial multiomics at single-cell resolution.

Feb 2026VizgenNews article